Young, Allan H.

Plasma cortisol-dehydroepiandrosterone (DHEA) ratios in schizophrenia and bipolar disorder

GALLAGHER, P., WATSON, S., SMITH, M., YOUNG, A., & FERRIER, I. (2007) · Schizophrenia Research

Stress Responses and CortisolSchizophrenia research and treatment

Cited by 129

The relationship between cortisol, stress and psychiatric illness: New insights using hair analysis

Herane Vives, A., De Angel, V., Papadopoulos, A., Strawbridge, R., Wise, T., Young, A. H., Arnone, D., & Cleare, A. J. (2015) · Journal of Psychiatric Research

Stress Responses and CortisolAdrenal Hormones and Disorders

Cited by 129

Identifying a cognitive impairment subgroup in adults with mood disorders

Iverson, G. L., Brooks, B. L., Langenecker, S. A., & Young, A. H. (2011) · Journal of Affective Disorders

Bipolar Disorder and TreatmentDementia and Cognitive Impairment Research

Cited by 124

Comparative Efficacy and Acceptability of Drug Treatments for Bipolar Depression: A Multiple-Treatments Meta-Analysis

Taylor, D. M., Cornelius, V., Smith, L., & Young, A. H. (2014) · Acta Psychiatrica Scandinavica

Bipolar Disorder and TreatmentTreatment of Major Depression

Cited by 122

Childhood trauma in bipolar disorder

Watson, S., Gallagher, P., Dougall, D., Porter, R., Moncrieff, J., Ferrier, I. N., & Young, A. H. (2014) · Australian & New Zealand Journal of Psychiatry

Bipolar Disorder and TreatmentChild Abuse and Trauma

Cited by 122

Cortisol in Mood Disorders

Young, A. H. (2004) · Stress

Stress Responses and CortisolAdrenal Hormones and Disorders

Cited by 111

Updated Review and Meta-Analysis of Probiotics for the Treatment of Clinical Depression: Adjunctive vs. Stand-Alone Treatment

Nikolova, V., Cleare, A., Young, A., & Stone, J. (2021) · Journal of Clinical Medicine

Probiotics and Fermented FoodsTryptophan and brain disorders

Cited by 106

Inflammation as a treatment target in mood disorders: review

Jones, B. D. M., Daskalakis, Z. J., Carvalho, A. F., Strawbridge, R., Young, A. H., Mulsant, B. H., & Husain, M. I. (2020) · BJPsych Open

Tryptophan and brain disordersTreatment of Major Depression

Cited by 106

Dementia rating and nicotinic receptor expression in the prefrontal cortex in schizophrenia

Martin-Ruiz, C. M., Haroutunian, V. H., Long, P., Young, A. H., Davis, K. L., Perry, E. K., & Court, J. A. (2003) · Biological Psychiatry

Nicotinic Acetylcholine Receptors StudySchizophrenia research and treatment

Cited by 100

Clinical research challenges posed by difficult-to-treat depression.

Rush, A. J., Sackeim, H. A., Conway, C. R., Bunker, M. T., Hollon, S. D., Demyttenaere, K., Young, A. H., Aaronson, S. T., Dibué, M., Thase, M. E., et al. (2022) · Psychological Medicine

Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 89

The prevalence and incidence of perinatal anxiety disorders among women experiencing a medically complicated pregnancy

Fairbrother, N., Young, A. H., Zhang, A., Janssen, P., & Antony, M. M. (2017) · Archives of Women s Mental Health

Maternal Mental Health During Pregnancy and PostpartumMaternal and Neonatal Healthcare

Cited by 88

Systematic review and meta-analysis of augmentation and combination treatments for early-stage treatment-resistant depression

Scott, F., Hampsey, E., Gnanapragasam, S., Carter, B., Marwood, L., Taylor, R. W., Emre, C., Korotkova, L., Martín-Dombrowski, J., Cleare, A. J., et al. (2023) · Journal of Psychopharmacology

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 87

Pharmacological Augmentation in Unipolar Depression: A Guide to the Guidelines

Taylor, R. W., Marwood, L., Oprea, E., DeAngel, V., Mather, S., Valentini, B., Zahn, R., Young, A. H., & Cleare, A. J. (2020) · International Journal of Neuropsychopharmacology

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 76

Clinical characteristics of patients assessed within an Improving Access to Psychological Therapies (IAPT) service: results from a naturalistic cohort study (Predicting Outcome Following Psychological Therapy; PROMPT)

Hepgul, N., King, S., Amarasinghe, M., Breen, G., Grant, N., Grey, N., Hotopf, M., Moran, P., Pariante, C. M., Tylee, A., et al. (2016) · BMC Psychiatry

Psychotherapy Techniques and ApplicationsAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 64

Bipolar Disorder is associated with the rs6971 polymorphism in the gene encoding 18 kDa Translocator Protein (TSPO)

Colasanti, A., Owen, D. R., Grozeva, D., Rabiner, E. A., Matthews, P. M., Craddock, N., & Young, A. H. (2013) · Psychoneuroendocrinology

Bipolar Disorder and TreatmentGenetic Associations and Epidemiology

Cited by 55

Effectiveness of pharmacogenomic tests including CYP2D6 and CYP2C19 genomic variants for guiding the treatment of depressive disorders: Systematic review and meta-analysis of randomised controlled trials

Arnone, D., Omar, O., Arora, T., Östlundh, L., Ramaraj, R., Javaid, S., Govender, R. D., Ali, B. R., Patrinos, G. P., Young, A. H., et al. (2023) · Neuroscience & Biobehavioral Reviews

Pharmacogenetics and Drug MetabolismTreatment of Major Depression

Cited by 53

Is a SIMPLe smartphone application capable of improving biological rhythms in bipolar disorder?

Hidalgo-Mazzei, D., Reinares, M., Mateu, A., Juruena, M. F., Young, A. H., Pérez-Sola, V., Vieta, E., & Colom, F. (2017) · Journal of Affective Disorders

Bipolar Disorder and TreatmentDigital Mental Health Interventions

Cited by 52

Relative effectiveness of augmentation treatments for treatment-resistant depression: a systematic review and network meta-analysis

Carter, B., Strawbridge, R., Husain, M. I., Jones, B. D. M., Short, R., Cleare, A. J., Tsapekos, D., Patrick, F., Marwood, L., Taylor, R. W., et al. (2020) · International Review of Psychiatry

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 47

Elevated fingernail cortisol levels in major depressive episodes

Herane-Vives, A., Fischer, S., de Angel, V., Wise, T., Cheung, E., Chua, K.-C., Arnone, D., Young, A. H., & Cleare, A. J. (2018) · Psychoneuroendocrinology

Stress Responses and CortisolTreatment of Major Depression

Cited by 46

A randomised, placebo-controlled 52-week trial of continued quetiapine treatment in recently depressed patients with bipolar I and bipolar II disorder

Young, A. H., McElroy, S. L., Olausson, B., Paulsson, B., (D1447C00001), O. B. O. T. E. I., & Embolden II (D1447C00134) Investigators (2014) · The World Journal of Biological Psychiatry

Bipolar Disorder and TreatmentTreatment of Major Depression

Cited by 46

Chronotherapy for the rapid treatment of depression: a meta-analysis

Humpston, C., Benedetti, F., Serfaty, M., Markham, S., Hodsoll, J., Young, A. H., & Veale, D. (2020) · Journal of Affective Disorders

Treatment of Major DepressionCircadian rhythm and melatonin

Cited by 45

Baseline cortisol and the efficacy of antiglucocorticoid treatment in mood disorders: A meta-analysis

Lombardo, G., Enache, D., Gianotti, L., Schatzberg, A. F., Young, A. H., Pariante, C. M., & Mondelli, V. (2019) · Psychoneuroendocrinology

Stress Responses and CortisolTreatment of Major Depression

Cited by 45

The progesterone metabolite allopregnanolone potentiates GABAA receptor-mediated inhibition of 5-HT neuronal activity

Kaura, V., Ingram, C. D., Gartside, S. E., Young, A. H., & Judge, S. J. (2007) · European Neuropsychopharmacology

Neuroscience and Neuropharmacology ResearchNeurotransmitter Receptor Influence on Behavior

Cited by 44

Real‐world evidence from a European cohort study of patients with treatment resistant depression: healthcare resource utilization

Heerlein, K., De Giorgi, S., Degraeve, G., Frodl, T., Hagedoorn, W., Oliveira-Maia, A. J., Otte, C., Perez Sola, V., Rathod, S., Rosso, G., et al. (2022) · Journal of Affective Disorders

Treatment of Major DepressionMental Health Treatment and Access

Cited by 44